We are live on ! Find out more
ACP

Ashfield Capital Partners Portfolio holdings

AUM $1.19B
1-Year Est. Return 14.56%
This Fund
S&P 500
This Quarter Est. Return
+1.56%
1 Year Est. Return
-14.56%
3 Year Est. Return
+48.8%
5 Year Est. Return
+97.38%
10 Year Est. Return
AUM
$1.4B
AUM Growth
+$1.57M
Cap. Flow
-$8.26M
Cap. Flow %
-0.59%
Top 10 Hldgs %
36.8%
Holding
236
New
4
Increased
61
Reduced
84
Closed
5

Top Buys

Rank Stock Value
1
BNTX icon
BioNTech
BNTX
+$4.46M
2
PANW icon
Palo Alto Networks
PANW
+$3.16M
3
BX icon
Blackstone
BX
+$1.74M
4
TJX icon
TJX Companies
TJX
+$1.53M
5
AVB icon
AvalonBay Communities
AVB
+$1.21M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$6.54M
2
TDOC icon
Teladoc Health
TDOC
+$5.62M
3
TWLO icon
Twilio
TWLO
+$3.78M
4
AAPL icon
Apple
AAPL
+$1.45M
5
BFAM icon
Bright Horizons
BFAM
+$1.04M

Sector Composition

Rank Sector Weight
1 Technology 32.94%
2 Healthcare 16.58%
3 Consumer Discretionary 9.3%
4 Communication Services 8.27%
5 Industrials 7.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PG icon
26
Procter & Gamble
PG
$336B
$13.5M 0.96%
96,233
-549
-0.6% -$77.8K
NKE icon
27
Nike
NKE
$61.9B
$12.7M 0.91%
87,655
+773
+0.9% +$126K
CAT icon
28
Caterpillar
CAT
$375B
$12.5M 0.89%
65,311
+682
+1% +$142K
AMGN icon
29
Amgen
AMGN
$208B
$12.2M 0.87%
57,290
-378
-0.7% -$87K
VIG icon
30
Vanguard Dividend Appreciation ETF
VIG
$111B
$11.7M 0.84%
76,479
-383
-0.5% -$61K
HON icon
31
Honeywell
HON
$77B
$11.5M 0.82%
57,310
+307
+0.5% +$65.4K
EL icon
32
Estee Lauder
EL
$30.4B
$11.4M 0.81%
38,006
+175
+0.5% +$57.2K
CVX icon
33
Chevron
CVX
$392B
$11M 0.79%
108,915
+105
+0.1% +$10.5K
ABT icon
34
Abbott
ABT
$183B
$10.7M 0.76%
90,369
-1,241
-1% -$152K
PANW icon
35
Palo Alto Networks
PANW
$270B
$10.5M 0.75%
131,340
+44,922
+52% +$3.16M
PYPL icon
36
PayPal
PYPL
$48.9B
$10.5M 0.75%
40,220
+192
+0.5% +$54.5K
INTC icon
37
Intel
INTC
$455B
$10.4M 0.74%
195,358
-1,990
-1% -$108K
VTI icon
38
Vanguard Morningstar Total Stock Market ETF
VTI
$660B
$10.4M 0.74%
46,784
-8
-0% -$1.82K
ABBV icon
39
AbbVie
ABBV
$443B
$10.4M 0.74%
96,286
-1,824
-2% -$208K
SHW icon
40
Sherwin-Williams
SHW
$82.7B
$10.1M 0.72%
35,943
+189
+0.5% +$55.3K
WMT icon
41
Walmart Inc
WMT
$885B
$10M 0.71%
215,484
+1,002
+0.5% +$48.3K
MCD icon
42
McDonald's
MCD
$192B
$9.79M 0.7%
40,608
-205
-0.5% -$48.9K
IQV icon
43
IQVIA
IQV
$38.7B
$8.82M 0.63%
36,823
+428
+1% +$108K
CRM icon
44
Salesforce
CRM
$151B
$8.68M 0.62%
31,996
+893
+3% +$227K
TREX icon
45
Trex
TREX
$4.51B
$8.61M 0.61%
84,454
+1,289
+2% +$135K
MS icon
46
Morgan Stanley
MS
$331B
$8.49M 0.6%
87,218
+460
+0.5% +$45.6K
RTX icon
47
RTX Corp
RTX
$290B
$7.93M 0.56%
92,212
+1,239
+1% +$106K
MMM icon
48
3M
MMM
$90.9B
$7.77M 0.55%
52,994
-105
-0.2% -$17K
VEEV icon
49
Veeva Systems
VEEV
$33.1B
$7.77M 0.55%
26,969
+60
+0.2% +$19K
BX icon
50
Blackstone
BX
$102B
$7.47M 0.53%
64,194
+14,960
+30% +$1.74M

Similar funds

Ashfield Capital Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Ashfield Capital Partners held 236 positions worth $1.4B, up 0.11% from $1.4B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 3.8%. Ashfield Capital Partners opened 4 new positions and exited 5, leaving the 236-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Ashfield Capital Partners's largest Q3 2021 buy was BioNTech: 14,020 shares worth $3.83M.
  • Ashfield Capital Partners added most to Palo Alto Networks in Q3 2021, an estimated $3.16M increase.
  • Ashfield Capital Partners's biggest Q3 2021 reduction was Alibaba, cutting an estimated $6.54M.
  • Ashfield Capital Partners fully exited Teladoc Health in Q3 2021, selling an estimated $5.62M.
  • Ashfield Capital Partners's ten largest holdings make up 37% of its $1.4B portfolio in Q3 2021.
  • Ashfield Capital Partners opened 4 new positions and closed 5 in Q3 2021.
  • Ashfield Capital Partners's portfolio value rose 0.11% quarter-over-quarter to $1.4B.

Based on Ashfield Capital Partners's 13F filing for Q3 2021, filed 9 Nov 2021.